Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$517M |
| 2 |
NXP Semiconductors
NXPI
|
+$351M |
| 3 |
Oracle
ORCL
|
+$279M |
| 4 |
Palo Alto Networks
PANW
|
+$268M |
| 5 |
Boston Scientific
BSX
|
+$204M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CERN
Cerner Corp
CERN
|
+$517M |
| 2 |
ExxonMobil
XOM
|
+$385M |
| 3 |
Cenovus Energy
CVE
|
+$292M |
| 4 |
PLAN
Anaplan, Inc.
PLAN
|
+$236M |
| 5 |
Phillips 66
PSX
|
+$222M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.76% |
| 2 | Financials | 7.62% |
| 3 | Healthcare | 7.1% |
| 4 | Industrials | 5.08% |
| 5 | Consumer Discretionary | 4.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SOHU
3351
Sohu.com
SOHU
$376M
| $2.71M | ﹤0.01% |
163,295
-29,338
| -15% | -$458K |
|
3352
Fulgent Genetics
FLGT
$528M
| $2.7M | ﹤0.01% |
49,575
-231,361
| -82% | -$12.7M |
|
3353
EyePoint Inc
EYPT
$1.09B
| $2.7M | ﹤0.01% |
343,223
+187,958
| +121% | +$1.89M |
|
3354
CALL
Best Buy
BBY
$17.6B
| $2.7M | ﹤0.01% |
41,400
-21,900
| -35% | -$1.83M |
|
3355
PUT
KKR & Co
KKR
$99.6B
| $2.69M | ﹤0.01% |
58,200
+48,900
| +526% | +$2.57M |
|
3356
PUT
Fortive
FTV
$18.7B
| $2.69M | ﹤0.01% |
+65,687
| New | +$2.91M |
|
3357
Alaunos Therapeutics
TCRT
$4.79M
| $2.69M | ﹤0.01% |
14,465
+10,852
| +300% | +$1.04M |
|
3358
PUT
Roblox
RBLX
$26.2B
| $2.69M | ﹤0.01% |
81,800
+11,800
| +17% | +$396K |
|
|
BWIN
3359
Baldwin Insurance Group
BWIN
$2.84B
| $2.69M | ﹤0.01% |
111,255
-277,666
| -71% | -$6.75M |
|
3360
Coca-Cola Consolidated
COKE
$12.1B
| $2.68M | ﹤0.01% |
47,460
+22,540
| +90% | +$1.18M |
|
|
AFCG
3361
AFC Gamma
AFCG
$63.6M
| $2.67M | ﹤0.01% |
254,353
-20,159
| -7% | -$236K |
|
3362
SiriusXM
SIRI
$9.66B
| $2.67M | ﹤0.01% |
43,525
-403,728
| -90% | -$25.1M |
|
|
KZR
3363
CALL
DELISTED
Kezar Life Sciences
KZR
| $2.67M | ﹤0.01% |
32,240
+27,240
| +545% | +$2.4M |
|
|
WPRT
3364
Westport Fuel Systems
WPRT
$36.7M
| $2.66M | ﹤0.01% |
263,770
+94,267
| +56% | +$1.17M |
|
3365
Corvus Pharmaceuticals
CRVS
$1.2B
| $2.66M | ﹤0.01% |
2,687,943
-35,596
| -1% | -$43.7K |
|
3366
CALL
Crown Castle
CCI
$31.4B
| $2.66M | ﹤0.01% |
15,800
+1,100
| +7% | +$200K |
|
3367
Oramed Pharmaceuticals
ORMP
$176M
| $2.66M | ﹤0.01% |
580,383
+216,823
| +60% | +$1.16M |
|
|
RPT
3368
Rithm Property Trust
RPT
$98M
| $2.65M | ﹤0.01% |
46,141
+38,283
| +487% | +$2.29M |
|
3369
SL Green Realty
SLG
$3.98B
| $2.65M | ﹤0.01% |
57,415
-190,927
| -77% | -$12.1M |
|
|
IQMD
3370
DELISTED
Intelligent Medicine Acquisition Corp. Class A Common Stock
IQMD
| $2.65M | ﹤0.01% |
+264,160
| New | +$2.64M |
|
|
CFIV
3371
DELISTED
CF Acquisition Corp. IV Class A common stock
CFIV
| $2.65M | ﹤0.01% |
268,758
+12,631
| +5% | +$124K |
|
|
FRBN
3372
DELISTED
Forbion European Acquisition Corp. Class A Ordinary Shares
FRBN
| $2.65M | ﹤0.01% |
264,482
+215,354
| +438% | +$2.15M |
|
|
GRTS
3373
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
| $2.64M | ﹤0.01% |
1,091,467
+488,923
| +81% | +$1.28M |
|
3374
CytomX Therapeutics
CTMX
$750M
| $2.64M | ﹤0.01% |
1,441,732
-803,458
| -36% | -$1.54M |
|
|
WW
3375
DELISTED
WW International
WW
| $2.64M | ﹤0.01% |
412,805
-203,275
| -33% | -$1.71M |
|
Similar funds
Millennium Management's Q2 2022 Portfolio in Review
As of Q2 2022, Millennium Management held 7,971 positions worth $161B, down 15% from $189B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Millennium Management deployed $7.94B of net new capital in Q2 2022, opening 1,144 new positions and adding to 2,588 existing holdings. Its largest new stake was M&T Bank: 828,809 shares worth $132M.
By sector, the portfolio is most concentrated in Technology at 7.8% of assets, up from 7.2% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was ExxonMobil, an estimated $385M trimmed.
- Millennium Management's largest Q2 2022 buy was M&T Bank: 828,809 shares worth $132M.
- Millennium Management added most to Invesco QQQ Trust in Q2 2022, an estimated $517M increase.
- Millennium Management's biggest Q2 2022 reduction was ExxonMobil, cutting an estimated $385M.
- Millennium Management fully exited Cerner Corp in Q2 2022, selling an estimated $517M.
- Millennium Management's ten largest holdings make up 23% of its $161B portfolio in Q2 2022.
- Millennium Management opened 1,144 new positions and closed 1,065 in Q2 2022.
- Millennium Management's portfolio value fell 15% quarter-over-quarter to $161B.
Based on Millennium Management's 13F filing for Q2 2022, filed 15 Aug 2022.